Accounts Payable Analysis Prescribes $1.5 Million for Pharmaceutical Company
Accounts Payable Analysis Prescribes $1.5 Million for Pharmaceutical Company
1 PagesIndustry: Pharmaceuticals Annual Revenue: $473.2 Million Entity Type: Private Company Ownership Structure: LLC Geographic Footprint: National Client Profile Data Analytics Case Study www.cbiz.com/risk-advisory-services Accounts Payable Analysis Prescribes $1.5 Million for Pharmaceutical Company Issue A national pharmaceutical company that focused on reducing prescription drug costs for its customers was also looking for internal cost savings. The company was aware of the financial leakage risks that its current accounts payable (AP) function posed, including multiple payment systems and over $1 billion dollars in spend, but it did not have the specialized forensic expertise and resources necessary to address its risks. Solution Our data analytics team offered a technology-b
